Editorials Antipsychotics and the risk of venous thromboembolism BMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c4216 (Published 22 September 2010) Cite this as: BMJ 2010;341:c4216 Article Related content Metrics Responses Peer review Related articles Research Antipsychotic drugs and risk of venous thromboembolism: nested case-control study Published: 22 September 2010; BMJ 341 doi:10.1136/bmj.c4245 See more Generics have a chequered recent history BMJ December 05, 2016, 355 i6527; DOI: https://doi.org/10.1136/bmj.i6527 Pfizer could face large fine over pricing of generic phenytoin BMJ November 28, 2016, 355 i6401; DOI: https://doi.org/10.1136/bmj.i6401 Manufacturers tell FDA why they should be able to promote drugs and devices off label BMJ November 14, 2016, 355 i6098; DOI: https://doi.org/10.1136/bmj.i6098 Dietitians have important role in mental health team, say researchers BMJ November 03, 2016, 355 i5913; DOI: https://doi.org/10.1136/bmj.i5913 Women are unaware of pregnancy risks linked with sodium valproate BMJ October 31, 2016, 355 i5829; DOI: https://doi.org/10.1136/bmj.i5829 Cited by... Idiopathic pulmonary thromboembolism in the course of intensive psychiatric inpatient care: case report and treatment guidelinesAbstract Fulltext PDF
